A report shows that the combination of low CRY1 and low BMAL1 expression were prognostic factors in ovarian cancers, however, neither CRY1 nor BMAL1 were linked with the survival rates of patients suffering from ovarian cancers [89]. Here, BMAL1 is linked to ovarian carcinoma.